RxDoctor Payments Data

Kelly Eifling

Gerontology · North Richland Hills, TXNPI 1083371728

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 79.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $8,737 and has fallen 68.6% since, to $2,741 in 2025. Among gerontology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,709in general payments, 2019–2025

Across 112 payments — averaging $113.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$10K
  • Medtronic$1K
  • Johnson & Johnson$248
  • Biosense Webster, Inc.$209
  • E.r. Squibb & Sons, L.L.C.$209
  • Pfizer$141
  • plus $693 from 14 others

What the payments were for

  • Consulting fees$6,10048%
  • Travel & lodging$2,02516%
  • Food & beverage$4,58436%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,709 in reported general payments places this provider in the 95th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas

Medicare billing

Part B allowed, 2024
$90,297
Medicare patients
591
Services billed
1,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban199$178,748
XareltoRivaroxaban79$71,262
Flecainide Acetate112$3,304
Amiodarone Hcl221$2,775
Dofetilide18$1,283
Sotalol AfSotalol Hcl19$771
Diltiazem 24hr Er (Cd)Diltiazem Hcl39$708
Metoprolol Succinate71$569
SotalolSotalol Hcl19$475
Metoprolol Tartrate15$65
Carvedilol12$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$141$178,748199 claims
Johnson & JohnsonXarelto$248$71,26279 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 gerontology providers in Texas.

Other gerontology in North Richland Hills

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →